Liposomal alendronate for the treatment of restenosis.


The current treatment for coronary restenosis following balloon angioplasty involves the use of a mechanical or drug eluting stent (DES). The advent of DES systems has effectively allayed much of the challenge of restenosis that has plagued the success of percutaneous coronary interventions (PCI). However, there are certain limitations to DES use, among… (More)
DOI: 10.1016/j.jconrel.2011.11.037


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics